Medical Eligibility Required Semaglutide and Tirzepatide cannot be prescribed to individuals with the following conditions: BMI under 27, eating disorders, Type 1 diabetes, gallbladder disease, substance abuse, recent bariatric surgery (within the past 6 months), pancreatitis or history of recurrent pancreatitis while taking a GLP-1 medication, medullary thyroid cancer, current pregnancy or breastfeeding, plans to become pregnant, diabetic retinopathy, multiple endocrine neoplasia type 2 (MEN2) or family history of MEN2, serious gastrointestinal disorders, or history of allergic reaction to Tirzepatide or Semaglutide
Timing is individual: Weekly injection timing is usually flexible, but routines help
While ecnoglutide has not yet received formal marketing authorization for any indication in any country or region worldwide, in China, new drug applications (NDAs) are under review
CAUTION *Keep out of reach of children
It is especially effective when combined with a nutritious diet and regular exercise routine
Please stop by and tell them Ebonee sent you